Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Revenue (2016 - 2025)

Historic Revenue for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to $795950.0.

  • Abvc Biopharma's Revenue rose 10446.93% to $795950.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $433543.0, marking a year-over-year decrease of 1495.62%. This contributed to the annual value of $509589.0 for FY2024, which is 23431.02% up from last year.
  • Abvc Biopharma's Revenue amounted to $795950.0 in Q3 2025, which was up 10446.93% from -$129413.0 recorded in Q2 2025.
  • Abvc Biopharma's 5-year Revenue high stood at $795950.0 for Q3 2025, and its period low was -$393589.5 during Q4 2021.
  • Its 5-year average for Revenue is $108598.9, with a median of $31441.0 in 2021.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 235074.29% in 2024, then plummeted by 1959875.52% in 2025.
  • Abvc Biopharma's Revenue (Quarter) stood at -$393589.5 in 2021, then soared by 249.65% to $588994.0 in 2022, then plummeted by 99.63% to $2165.0 in 2023, then dropped by 9.19% to $1966.0 in 2024, then soared by 40385.76% to $795950.0 in 2025.
  • Its Revenue stands at $795950.0 for Q3 2025, versus -$129413.0 for Q2 2025 and -$234960.0 for Q1 2025.